Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay

Area of Science:

• Biochemistry
• Immunology
• Clinical Chemistry

Background:

• Accurate measurement of intact human parathyroid hormone (hPTH) is crucial for diagnosing disorders of calcium metabolism.
• Existing immunoassays for hPTH may lack specificity or rapidity.
• Distinguishing between primary hyperparathyroidism and other causes of hypercalcemia, such as malignancies, is clinically significant.

Purpose of the Study:

• To describe a novel direct immunoassay for quantifying circulating intact hPTH.
• To evaluate the specificity and sensitivity of the new assay for intact hPTH.
• To assess the assay's utility in differentiating between primary hyperparathyroidism and malignancy-associated hypercalcemia.

Main Methods:

• Development of a direct immunoassay utilizing a chemiluminescent aryl acridinium ester label.
• Immune complex formation involving labeled anti-amino-terminal PTH antibody, intact hPTH, and solid-phase anti-midregion PTH antibody.
• Quantification of bound luminescence using an automatic luminometer after separation of the bound fraction.

Main Results:

• The assay demonstrated high specificity for intact hPTH, with no significant interference from PTH fragments.
• A low detection limit of 0.8 pmol/L for hPTH-(1-84) allowed detection in all normal subjects.
• The assay successfully distinguished between hypercalcemic patients with primary hyperparathyroidism and those with malignancies.

Conclusions:

• The developed direct immunoassay provides a specific, rapid, and stable method for measuring intact hPTH.
• This assay is a valuable tool for investigating parathyroid physiology and clinical disorders of calcium metabolism.
• The assay's ability to differentiate hypercalcemic conditions improves diagnostic accuracy.